American Society of Hematology

The Hematologist: ASH News and Reports, the Society's member newsletter, is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

A Resounding Success: Inaugural Lymphoma Biology Meeting

Dr. Linda J. Burns reviews ASH's first meeting covering the latest lymphoma science.

Read more
View All

Presidents Column

Dr_ Linda Burns

Linda J. Burns, MD

Professor of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis
A Resounding Success: Inaugural Lymphoma Biology Meeting
October 22, 2014

Dr. Burns recaps the first lymphoma biology meeting.

View All

Clinical Trials Corner

Perioperative Management of Patients on the New Oral Anticoagulants
October 23, 2014

Dr. Garcia examines the usefulness of new oral anticoagulants.

View All

Ask The Hematologist

Ask the Hematologist: A Diagnostic Approach to Patients with an IgM monoclonal protein
September 15, 2014

Dr. Mikhael discusses his approach to the evaluation of patients with an IgM monoclonal protein.

View All

Mini Review

Progress in the Diagnosis and Management of Type 1 von Willebrand Disease
November 18, 2014

Drs. Jonathan Roberts, Robert Montgomery, and Gilbert C. White review recent progress in diagnosing and managing von Willebrand Disease.

View All

Op Ed

Is the NIH Expert Report on Sickle Cell Disease a “Clinical Practice Guideline We Can Trust?”
November 19, 2014

Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.

View All
  • SGR – Where Do We Go from Here?

    As the 113 th Congress winds down, it has become clear that this group of legislators will not be remembered as the one that permanently addressed the issues associated with Medicare physician payment.  Read more to find out what may happen with the SGR in 2015.

  • Friends of Cancer Research and Brookings Institution Address Oncology Drug Development at a Conference on Clinical Cancer Research

    The seventh-annual Conference on Clinical Cancer Research brought together leaders in cancer drug development from federal, health and regulatory agencies, academic research and the private sector for focused discussions on critical issues surrounding the development and regulation of cancer drugs and therapies.

  • ASH Pleased by Newly Released NHLBI Funding Opportunities for Stem Cell-Derived Blood Products for Therapeutic Use

    The National Heart, Lung and Blood Institute (NHLBI) is now accepting applications for  R01  Research Project Grants and  R41 / R43/44  Small Business Technology Transfer Grants that will support research addressing scientific questions to enable and accelerate the use of stem cell-derived blood products as therapeutics.  The application deadlines for these funding opportunities is February 15 and February 20, 2015, respectively.

  • Laboratory-Developed Tests and the FDA

    The FDA recently indicated that it wishes to begin to provide regulatory oversight of some laboratory-developed tests.  FDA is clear to indicate that it does not wish to include all tests in the regulatory process, and that it wishes to phase in this process over a period of years, starting with those tests that are most high risk. ASH is closely reviewing this proposed guidance in order to prepare comments for submission to the agency.

View all policy news
  • This Week in Blood: May 8, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

  • This Week in Blood: April 24, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

  • This Week in Blood: April 17, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

  • This Week in Blood: April 10, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

View all This Week in Blood
back to top